pills on chemical structures

University of Minnesota Trial Shows Hydroxychloroquine Has No Benefit Over Placebo in Preventing COVID-19

June 3, 2020

Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.

Other News

SeroNet COVID-19 Vaccine Response Study screenshot
The University of Minnesota is leading a research study that aims to better understand the immune system’s response to COVID-19 vaccines.…
Drs. Prasad and Natarajan
With the news of a COVID-19 outbreak in India and the World Health Organization urging countries to address global inequalities in health,…
medical reserve
As the fight against COVID-19 becomes a charge to quickly vaccinate Minnesotans—especially the most vulnerable—there remain key…